3 Things About Novavax That Smart Investors Know
Novavax (NASDAQ: NVAX) was last year's biggest coronavirus vaccine stock by far. The biotech company's shares soared more than 2,700% on optimism about its investigational vaccine.
Novavax has extended its gain this year. But it's lost a considerable amount of momentum after the company fell behind schedule in its plan to request regulatory authorization. Novavax plans on a submission in the third quarter, missing its earlier goal of the second quarter.
But that doesn't mean you should flee shares of this dynamic biotech company. Many smart investors continue to buy Novavax stock. Here are three things they know about the company that are inspiring them to stay invested for the long term.
Source Fool.com
